论文部分内容阅读
急性心肌梗塞(AMI)的治疗,近年取得了令人瞩目的进展。80年代以来治疗重点已从对恶性心律失常的防治转到旨在尽可能挽救濒死的心肌、缩小梗塞面积及预防再梗塞方面。溶栓治疗、经皮冠状动脉腔内成形术(PTCA)、紧急冠状动脉旁路移植手术(CABG)、激光冠脉成形术(CLA)、经皮血管腔内斑块旋切术(ATH)、金属血管支架(Stent)等治疗。使闭塞冠脉再通和/或再灌注,已成为AMI治疗的重要措施。 1溶栓治疗 Dewood等对AMI病人进行早期冠脉造影证实90%的病例有冠脉血栓,并通过CABG进一步证实造影结果。这一发现结束了多年来关于AMI与血栓因果关系的争论,
The treatment of acute myocardial infarction (AMI) has made remarkable progress in recent years. The focus of treatment since the 1980s has shifted from the prevention and treatment of malignant arrhythmias to those aimed at saving as much as possible the dying myocardium, reducing infarct size and preventing reinfarction. Thrombolytic therapy, percutaneous transluminal coronary angioplasty (PTCA), emergency coronary artery bypass graft surgery (CABG), laser coronary angioplasty (CLA), percutaneous endovascular angioplasty (ATH) Metal stent (Stent) and other treatment. Recanalization and / or reperfusion of occluded coronary arteries has become an important measure for the treatment of AMI. Thrombolysis Dewood et al. Coronary angiography in 90% of patients with AMI confirmed coronary angiography and further confirmed by CABG. This finding concludes over the years the controversy over the causal relationship between AMI and thrombosis,